menu
    • menu

    Company profile for Shanghai KangaBio

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    KangaBio, founded in 2021 by Dr. Weidong Jiang in Shanghai’s Zhangjiang Biomedicine Valley, is a biotech company developing innovative medicines for unmet medical needs. The organization focuses on prodrugs of immune-stimulating agents and multi-specific biologics to reduce toxicity and enhance efficacy for validated targets. Guided by values of speed, quality, globalization and accountability, KangaBio builds on leadership ...
    KangaBio, founded in 2021 by Dr. Weidong Jiang in Shanghai’s Zhangjiang Biomedicine Valley, is a biotech company developing innovative medicines for unmet medical needs. The organization focuses on prodrugs of immune-stimulating agents and multi-specific biologics to reduce toxicity and enhance efficacy for validated targets. Guided by values of speed, quality, globalization and accountability, KangaBio builds on leadership experience that includes the founding of Shanghai Henlius Biotech.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shanghai KangaBioChina Flag
    Country
    Country
    China
    Address
    Address
    Bldg 8, No.151 Libing Road,Pudong,Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kangabio.com/en-aboutus.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanyou Congratulates KangaBio on IND Approval for IL-12 Immunotherapy
    Sanyou Congratulates KangaBio on IND Approval for IL-12 Immunotherapy

    04 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sanyou-bio-congratulates-kangabio-on-their-ind-approval-for-next-generation-il-12-prodrug-cancer-immunotherapy-301976959.html

    PR NEWSWIRE
    04 Nov 2023
    Share Share
    Aton Biotech and KangaBio Enter Collaboration
    Aton Biotech and KangaBio Enter Collaboration

    21 Dec 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-12-21/aton-biotech-and-kangabio-enter-strategic-collaboration/

    CONTRACTPHARMA
    21 Dec 2022
    Share Share
    Sanyou and KangaBio partner to advance development of antibody drug
    Sanyou and KangaBio partner to advance development of antibody drug

    29 Aug 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/sanyou-kangabio-antibody-drug/

    PHARMACEUTICAL-TECHNOLOGY
    29 Aug 2022
    Share Share
    Sanyou & KangaBio established strategic collaboration
    Sanyou & KangaBio established strategic collaboration

    28 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sanyou-biopharmaceuticals-and-kangabio-established-strategic-collaboration-to-accelerate-antibody-drug-development-and-innovation-301611386.html

    PRNEWSWIRE
    28 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search